Conversely, silencing endogenous circITGa9 or inhibiting its binding to TPM3 effectively released TPM3 from its detrimental effects, thereby mitigating cardiac hypertrophy and fibrosis. This evidence concerns the gene TPM3 and cardiac hypertrophy.